![Cabozantinib N-oxide Impurity; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|1621681-63-7](https://drjcrbio.com/wp-content/uploads/1621681-63-7-.png)
Cabozantinib N-oxide Impurity; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|1621681-63-7
Cabozantinib, Cabozantinib N-oxide Impurity
Description
| Code: JCCZT-05 |
| CAS: 1621681-63-7 |
| Chemical Formula: C28H24FN3O6 |
| Molecular Weight: 517.51 |
| Category: Reference Standards/API Drug Metabolites/EP Impurities/USP Impurities |
| Literature: |
| Application: Cabozantinib N-oxide Impurity; 4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N’-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|1621681-63-7 is useful as reference Impurity standard. |
